← back to search

Andrew W. Borkowski

University of California San Diego · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immune Response and Inflammation, Prion Diseases and Protein Misfolding, Dermatology and Skin Diseases, and Antimicrobial Peptides and Activities.
h-index
18
citations
2,163
works
27
NIH funding
primary concept
email

Recent publications

Molecular cartography of the human skin surface in 3D
Proceedings of the National Academy of Sciences 2015cited by 362position: middledoi
Toll-Like Receptor 3 Activation Is Required for Normal Skin Barrier Repair Following UV Damage
Journal of Investigative Dermatology 2014cited by 69position: firstdoi
Methicillin-resistant Staphylococcus aureus Bacterial Nitric-oxide Synthase Affects Antibiotic Sensitivity and Skin Abscess Development
Journal of Biological Chemistry 2013cited by 103position: middledoi
Activation of TLR3 in Keratinocytes Increases Expression of Genes Involved in Formation of the Epidermis, Lipid Accumulation, and Epidermal Organelles
Journal of Investigative Dermatology 2013cited by 60position: firstdoi
Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases
Proceedings of the National Academy of Sciences 2013cited by 58position: middledoi
Resveratrol Stimulates Sphingosine-1-Phosphate Signaling of Cathelicidin Production
Journal of Investigative Dermatology 2013cited by 54position: middledoi
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
Nature Medicine 2012cited by 394position: middledoi
Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair
Journal of Investigative Dermatology 2012cited by 167position: middledoi
A Novel Role of a Lipid Species, Sphingosine-1-Phosphate, in Epithelial Innate Immunity
Molecular and Cellular Biology 2012cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard L. Gallo · University of San Diego7 papers (2012–2015)Kyungho Park · Convergence3 papers (2012–2013)Yoshikazu Uchida · Hallym University3 papers (2012–2013)Peter M. Elias · University of California, San Francisco2 papers (2012–2013)Benjamin Yu · Nanchang University2 papers (2012–2014)Walter M. Holleran · San Francisco VA Medical Center2 papers (2012–2013)Takeshi Yoshida · University of Rochester Medical Center2 papers (2012–2014)Lisa A. Beck · University of Rochester Medical Center2 papers (2012–2014)Pieter C. Dorrestein · University of Connecticut2 papers (2013–2015)Jamie J. Bernard · Michigan Department of Health and Human Services2 papers (2012–2014) · 2 papers (2012–2013)Teruaki Nakatsuji · Universidad Católica Santo Domingo2 papers (2012–2015)I‐Hsin Kuo · University of Rochester Medical Center2 papers (2012–2014)Melanie Hupe · University of California, San Francisco2 papers (2012–2013)Alan Jasanoff · Massachusetts Institute of Technology1 papers (2013–2013)Rob Knight · University of California San Diego1 papers (2015–2015)Christopher M. Rath · Adamas Pharmaceuticals (United States)1 papers (2015–2015) · 1 papers (2015–2015)Gitte Julie Moeller Christensen · Aarhus University1 papers (2015–2015)Nicki Watson · NanoScale Corporation (United States)1 papers (2013–2013)